Saaggifo Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-02-2023
- Paid Up Capital ₹ 0.10 M
as on 12-02-2023
- Company Age 10 Year, 16 Days
- Last Filing with ROC 31 Mar 2019
- Revenue -4.80%
(FY 2019)
- Profit 97.37%
(FY 2019)
- Ebitda 102.79%
(FY 2019)
- Net Worth -2.21%
(FY 2019)
- Total Assets -4.08%
(FY 2019)
About Saaggifo Chemicals And Pharmaceuticals
- CIN/LLPIN
U24100WB2015PTC204777
- Company No.
204777
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2015
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc-Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saaggifo Chemicals And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaaushik Kar  | Managing Director | 01-Jan-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Papia Kar | Director | 01-Jan-2015 | Current |
Financial Performance of Saaggifo Chemicals And Pharmaceuticals.
Saaggifo Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 4.8% decrease. The company also saw a substantial improvement in profitability, with a 97.37% increase in profit. The company's net worth dipped by a decrease of 2.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saaggifo Chemicals And Pharmaceuticals?
In 2017, Saaggifo Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saaggifo Club And Holiday Destinations Private LimitedActive 6 years 11 monthsKaaushik Kar and Papia Kar are mutual person
Saaggifo Technologies Private LimitedActive 8 years 7 monthsKaaushik Kar and Papia Kar are mutual person
- Saaggifo Global Services Private LimitedActive 7 years 9 months
Kaaushik Kar and Papia Kar are mutual person
- Saaggifo Infrastructures Private LimitedActive 7 years 3 months
Kaaushik Kar and Papia Kar are mutual person
- Saaggifo Motion Pictures Private LimitedActive 12 years 5 months
Kaaushik Kar and Papia Kar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saaggifo Chemicals And Pharmaceuticals?
Saaggifo Chemicals And Pharmaceuticals has a workforce of 25 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saaggifo Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saaggifo Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
